In summary, the findings of our research confirmed that DATS increased the chemosensitivity to cisplatin in the treatment of GC, and its mechanism may be related to the MAPK pathway, STAT3/PKC-δ, and endoplasmic reticulum stress. The gene discussed is PRKCD; the disease is gastric cancer.